Nadège Vimond
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Immunology top 5%
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
Papers in
-
- T-cell and B-cell Immunology 6
- Oncology 6
- Cancer Immunotherapy and Biomarkers 2
- Cancer Cells and Metastasis 1
- Co-authors
- Françoise Farace (5 shared papers)Nathalie Jacques (5 shared papers)Agnès Laplanche (2 shared papers)Philippe R. Vielh (2 shared papers)Fanny Billiot (2 shared papers)Karim S. Fizazi (1 shared paper)Sylvestre Le Moulec (1 shared paper)Ludovic Lacroix (1 shared paper)
- Journals
- Journal of Clinical Investigation (2 papers)British Journal of Cancer (2 papers)Frontiers in Immunology (2 papers)Blood Advances (2 papers)European Journal of Immunology (1 paper)
- Partner nations
- FranceUnited StatesGermany
In The Last Decade
Nadège Vimond
19 papers receiving 1.9k citations
Nadège Vimond's Hit Papers
Peers
Comparison fields: 5 of 75
- Oncology 516
- Immunology 324
- Cancer Research 210
- Molecular Biology 748
- Hepatology 99
Countries citing papers authored by Nadège Vimond
This map shows the geographic impact of Nadège Vimond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadège Vimond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadège Vimond more than expected).
Fields of papers citing papers by Nadège Vimond
This network shows the impact of papers produced by Nadège Vimond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadège Vimond. The network helps show where Nadège Vimond may publish in the future.
Co-authors
The 25 scholars most cited alongside Nadège Vimond, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC Hit paper breakdown → | 2015 | 690 |
| 2 | 2011 | 348 | |
| 3 | 2013 | 260 | |
| 4 | 2015 | 143 | |
| 5 | 2012 | 123 | |
| 6 | 2019 | 64 | |
| 7 | 2016 | 62 | |
| 8 | 2011 | 48 | |
| 9 | 2008 | 43 | |
| 10 | 2011 | 40 | |
| 11 | 2020 | 24 | |
| 12 | 2019 | 22 | |
| 13 | 2016 | 21 | |
| 14 | 2022 | 16 | |
| 15 | 2020 | 15 | |
| 16 | 2020 | 13 | |
| 17 | 2022 | 12 | |
| 18 | 2022 | 10 | |
| 19 | 2026 | 1 |
About Nadège Vimond
Nadège Vimond is a scholar working on Immunology, Oncology, Molecular Biology, Gastroenterology and Hepatology, having authored 19 papers that have together received 2k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (6 papers), Cancer Immunotherapy and Biomarkers (2 papers), Angiogenesis and VEGF in Cancer (2 papers), Gastrointestinal Tumor Research and Treatment (1 paper), Multiple Sclerosis Research Studies (1 paper), Cancer Cells and Metastasis (1 paper), Extracellular vesicles in disease (1 paper) and Hepatocellular Carcinoma Treatment and Prognosis (1 paper). The work is most often cited by research in Oncology (516 citations), Immunology (324 citations), Cancer Research (210 citations), Molecular Biology (748 citations) and Hepatology (99 citations). Nadège Vimond has collaborated with scholars based in France, United States and Germany. Frequent co-authors include Françoise Farace, Nathalie Jacques, Agnès Laplanche, Philippe R. Vielh, Fanny Billiot, Karim S. Fizazi, Sylvestre Le Moulec, Ludovic Lacroix, Christophe Massard and Fabrice André. Their work appears in journals such as Journal of Clinical Investigation, British Journal of Cancer, Frontiers in Immunology, Blood Advances and European Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.